| HYI |
Homo sapiens |
|
HYI is differentially expressed in 70 experiments [83 up/82 dn]: 17 organism parts: skeletal muscle [1 up/1 dn], white blood cells [0 up/1 dn], ...; 21 disease states: normal [5 up/2 dn], breast carcinoma [1 up/1 dn], ...; 25 cell types, 34 cell lines, 13 compound treatments and 15 other conditions. |
| HT036, HYI, RP11-506B15.5-003, RP11-506B15.5-005, SB156, RP11-506B15.5-004 |
|
C05D11.5 (Caenorhabditis elegans)
zgc:63850 (Danio rerio)
Hyi (Mus musculus)
(Compare orthologs)
|
|
|
| Xylose isomerase, TIM barrel domain, Xylose isomerase-like, TIM barrel domain |
|
|
| hydroxypyruvate isomerase activity, isomerase activity |
|
|
|
Q5T013
Q5T014
Q5T015
Q5T017
|
|
|
|
ENSG00000178922
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
HL-60
|
Cell line |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
Stromal cell
|
Cell type |
|
|
MK886
|
Compound treatment |
|
|
Endothelial cell
|
Cell type |
|
|
Breast carcinoma
|
Disease state |
|
|
Skeletal muscle
|
Organism part |
|
|
N/a
|
Test result |
|
|
Not applicable
|
Histology |
|
|
Monocyte
|
Cell type |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
PC3
|
Cell line |
|
|
White blood cells
|
Organism part |
|
|
MKN74
|
Cell line |
|
|
SNU1
|
Cell line |
|
|
Caudate nucleus
|
Organism part |
|
|
Cerebellum
|
Organism part |
|
|
Tumor
|
Organism part |
|
|
AZ521
|
Cell line |
|
|
Uninfected
|
Infection |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Met5A
|
Cell line |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
YCC16
|
Cell line |
|
|
BT474
|
Cell line |
|
|
A549
|
Cell line |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
MKN7
|
Cell line |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Epithelial cell
|
Cell type |
|
|
Spermatid
|
Cell type |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
MDA468
|
Cell line |
|
|
HTERT/HPVE6/HPVE7/SV40t transf...
|
Gene modification |
|
|
YCC1
|
Cell line |
|
|
Testis
|
Organism part |
|
|
Whole blood
|
Organism part |
|
|
Homo sapiens
|
Organism |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Spermatocyte
|
Cell type |
|
|
HPL1
|
Cell line |
|
|
Seminiferous tubule
|
Organism part |
|
|
Fibroblast
|
Cell type |
|
|
Cartilage
|
Organism part |
|
|
MCF-7
|
Cell line |
|
|
SKBR3
|
Cell line |
|
|
Primary gastric tumor
|
Organism part |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
MKN45
|
Cell line |
|
|
Macaca mulatta
|
Organism |
|
|
Undifferentiated
|
Phenotype |
|
|
Differentiated
|
Phenotype |
|
|
Phorbol 12-myristate 13-acetat...
|
Compound treatment |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
MDA-MB-231
|
Cell line |
|
|
10 ng/ml LPS in media
|
Growth condition |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
MKN1
|
Cell line |
|
|
Superior cervical ganglion
|
Organism part |
|
|
HTERT transfection
|
Gene modification |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
SKMEL5
|
Cell line |
|
|
Macrophage
|
Cell type |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Obesity
|
Disease state |
|
|
CD4+ T cell
|
Cell type |
|
|
CD8+ T cell
|
Cell type |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
U937
|
Cell line |
|
|
Plasmacytoid dendritic cell
|
Cell type |
|
|
Beas2B
|
Cell line |
|
|
Media only
|
Growth condition |
|
|
Placebo
|
Compound treatment |
|
|
Glutamine
|
Compound treatment |
|
|
Neutrophil
|
Cell type |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Vasectomized
|
Clinical history |
|
|
Epidermal growth factor
|
Compound treatment |
|
|
SsMCF7
|
Cell line |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
Control for heregulin
|
Compound treatment |
|
|
HeLa
|
Cell line |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
SNU5
|
Cell line |
|
|
CD3int CD4+ CD8+
|
Phenotype |
|
|
Double positive thymocyte
|
Cell type |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Plasma cell leukemia
|
Disease state |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
BT-474
|
Cell line |
|
|
Liver
|
Organism part |
|
|
Breast cancer
|
Disease state |
|
|
Cervical cancer
|
Disease state |
|
|
Multiple myeloma
|
Disease state |
|
|
Gleason 8+
|
Tumor grading |
|
|
YCC3
|
Cell line |
|
|
Malignant melanoma
|
Disease state |
|
|
HaCaT
|
Cell line |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
T47-D
|
Cell line |
|
|
XBP1 overexpression
|
Genotype |
|
|
721 B lymphoblast
|
Cell type |
|
|
Wild_type
|
Genotype |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Acute myeloid leukemia
|
Disease state |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Keratinocyte
|
Cell type |
|
|
Heart
|
Organism part |
|
|
Cardiac myocyte
|
Cell type |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
Prostate cancer
|
Disease state |
|
|
Leydig cell
|
Cell type |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
T47D
|
Cell line |
|
|
Type 2B
|
Histology |
|
|
HTERT/HPVE6 transfection
|
Gene modification |
|
|
Anaplastic mixed oligo-astrocy...
|
Disease state |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Monoclonal gammopathy of undet...
|
Disease state |
|
|
IBL4
|
Cell line |
|
|
Vanadium pentoxide
|
Compound treatment |
|
|
Hs746T
|
Cell line |
|
|
|
|
|
Processing time: 0.109 secs.